Stakeholders have been previously advised about the condition placed on all Prescribed List billing codes for surgical guides and biomodels.
The Private Health Insurance (Medical Devices and Human Tissue Products) Amendment Rules (No. 2) 2023, made in November 2023 provide this condition.
Since the condition was published, we have received a range of questions and requests for clarification from stakeholders on the intent and operation of the condition.
We have compiled some of the most frequently asked questions and provide answers in this FAQ document.